In this study, we demonstrated that FOXO3a inhibited mammosphere formation ability, percentages of ALDH+ cells, subpopulation of CD44+/CD24− cells in vitro, and tumorigenicity in vivo, which supported an important role of FOXO3a in inhibiting CSC properties of breast cancer cells. This evidence concerns the gene LDHA and breast cancer.